SynBiotic SE Stock Xetra

Equities

SBX

DE000A3E5A59

Pharmaceuticals

Real-time Estimate Tradegate 03:07:39 2024-06-27 EDT 5-day change 1st Jan Change
7.49 EUR -0.66% Intraday chart for SynBiotic SE -6.45% +155.59%

Financials

Sales 2021 9.06 8.48 12.41 Sales 2022 8.17 7.64 11.18 Capitalization 37.92M 35.46M 51.92M
Net income 2021 -12M -11.22M -16.43M Net income 2022 -24M -22.44M -32.86M EV / Sales 2021 10,783,962 x
Net Debt 2021 215K 201K 294K Net Debt 2022 3.17M 2.96M 4.34M EV / Sales 2022 5,031,340 x
P/E ratio 2021
-7.04 x
P/E ratio 2022
-1.73 x
Employees 104
Yield 2021 *
-
Yield 2022
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.99%
1 week-6.45%
Current month-8.05%
1 month-16.96%
3 months-40.16%
6 months+151.33%
Current year+155.59%
More quotes
1 week
7.00
Extreme 7
7.62
1 month
7.00
Extreme 7
8.94
Current year
2.98
Extreme 2.98
19.50
1 year
2.86
Extreme 2.86
19.50
3 years
2.86
Extreme 2.86
41.80
5 years
2.86
Extreme 2.86
41.80
10 years
2.86
Extreme 2.86
41.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-08-20
Director of Finance/CFO - 22-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
More insiders
Date Price Change Volume
24-06-26 7.54 +0.53% 1 849
24-06-25 7.5 +0.54% 2,707
24-06-24 7.46 +0.81% 1,963
24-06-21 7.4 -4.64% 7,012
24-06-20 7.76 -3.72% 8,078

Delayed Quote Xetra, June 26, 2024 at 11:36 am

More quotes
SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.
More about the company

Annual profits - Rate of surprise